EUVIMEDEUVIMED entdecken
Crossref

Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis

Valentina Ferri, Emilio Vicente, Yolanda Quijano, Hipolito Duran, Eduardo Diaz, Isabel Fabra, Luis Malave, Pablo Ruiz, Giulia Costantini, Giada Pizzuti, Antonio Cubillo, Maria Carmen Rubio und 3 weitere

International Journal of Colorectal Disease · 05.12.2023 · 38 (1)

DOI: 10.1007/s00384-023-04573-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 05.12.2023. Verfasst von Valentina Ferri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, HM-Sanchinarro University Hospital, San Pablo University, Calle Oña 10, 28050, Madrid, Spain. valenpeglio@gmail.com. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Rectal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The watch-and-wait (WW) strategy is a potential option for patients with rectal cancer who obtain a complete clinic response after neoadjuvant therapy. The aim of this study is to analyze the long-term oncological outcomes and perform a cost-effectiveness analysis in patients undergoing this strategy for rectal cancer. MATERIAL AND METHODS: The data of patients treated with the WW strategy were prospectively collected from January 2015 to January 2020. A control group was created, matched 1:1 from a pool of 480 patients undergoing total mesorectal excision. An independent company carried out the financial analysis. Clinical and oncological outcomes were analyzed in both groups. Outcome parameters included surgical and follow-up costs, quality-adjusted life years (QALYs), and the incremental cost per QALY gained or the incremental cost-effectiveness ratio (ICER). RESULTS: Forty patients were included in the WW group, with 40 patients in the surgical group. During a median follow-up period of 36 months, metastasis-free survival (MFS) and overall survival (OS) were similar in the two groups. In the WW group, nine (22%) local regrowths were detected in the first 2 years. The permanent stoma rate was slightly higher after salvage surgery in the WW group compared to the surgical group (48.5% vs 20%, p < 0.01). The cost-effectiveness analysis was slightly better for the WW group, especially for low rectal cancer compared to medium-high rectal cancer (ICER = - 108,642.1 vs ICER = - 42,423). CONCLUSIONS: The WW strategy in locally advanced rectal cancer offers similar oncological outcomes with respect to the surgical group and excellent results in quality of life and cost outcomes, especially for low rectal cancer. Nonetheless, the complex surgical field during salvage surgery can lead to a high permanent stoma rate; therefore, the careful selection of patients is mandatory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Effectiveness AnalysisRectal NeoplasmsHumansQuality of LifeRectumRemission InductionNeoadjuvant TherapyWatchful WaitingNeoplasm Recurrence, LocalTreatment OutcomeChemoradiotherapy

Stichwörter der Autor:innen

Neoadjuvant chemoradiotherapyRectal cancerWatch-and-wait (WW) strategy

Autor:innen und Institutionen

  • Division of General Surgery, HM-Sanchinarro University Hospital, San Pablo University, Calle Oña 10, 28050, Madrid, Spain. valenpeglio@gmail.com.
  • Division of General Surgery, HM-Sanchinarro University Hospital, San Pablo University, Calle Oña 10, 28050, Madrid, Spain.
  • University of Pavia, Pavia, Italy.
  • Oncology Department, HM-Sanchinarro University Hospital, Madrid, Spain.
  • Radiotherapy Department, HM-Sanchinarro University Hospital, Madrid, Spain.
  • Nuclear Medicine Department, HM-Sanchinarro University Hospital, Madrid, Spain.

Zitieren

APA

Ferri, V., Vicente, E., Quijano, Y., Duran, H., Diaz, E., Fabra, I., Malave, L., Ruiz, P., Costantini, G., Pizzuti, G., Cubillo, A., Rubio, M. C., Cañamaque, L. G., Alfonsel, J. N., & Caruso, R. (2023). Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis. International Journal of Colorectal Disease, 38(1). https://doi.org/10.1007/s00384-023-04573-9

Vancouver

Ferri V, Vicente E, Quijano Y, Duran H, Diaz E, Fabra I, et al. Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis. International Journal of Colorectal Disease. 2023;38(1). doi:10.1007/s00384-023-04573-9

BibTeX
@article{Ferri2023,
  author = {Ferri, Valentina and Vicente, Emilio and Quijano, Yolanda and Duran, Hipolito and Diaz, Eduardo and Fabra, Isabel and Malave, Luis and Ruiz, Pablo and Costantini, Giulia and Pizzuti, Giada and Cubillo, Antonio and Rubio, Maria Carmen and Cañamaque, Lina Garcia and Alfonsel, Javier Nuñez and Caruso, Riccardo},
  title = {Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis},
  journal = {International Journal of Colorectal Disease},
  year = {2023},
  volume = {38},
  number = {1},
  doi = {10.1007/s00384-023-04573-9}
}
Kostenlos starten →